← FDA Drug Approvals (Drugs@FDA)

LEVOCETIRIZINE DIHYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANKALP LIFECARE · Approved 2018-11-20

Drug application

FDA Application #
ANDA211551
Application type
Abbreviated New Drug Application (Generic)
Brand name
LEVOCETIRIZINE DIHYDROCHLORIDE
Generic name
LEVOCETIRIZINE DIHYDROCHLORIDE
Active ingredients
LEVOCETIRIZINE DIHYDROCHLORIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Over-the-counter
Sponsor
SANKALP LIFECARE
Manufacturer
VELOCITY PHARMA LLC
First approval
2018-11-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown